Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
Conditions
- Pancreatic Cancer Resectable
Interventions
- BIOLOGICAL: individualized anti-tumor new antigen iNeo-Vac-R01 injection
- DRUG: Gemcitabine + Capecitabine
- DRUG: Sintilimab injection
Sponsor
Zhejiang University
Collaborators